12P - Ductal carcinoma in situ of the breast: Immune cell composition according to subtype
Authors
- Marie Colombe Agahozo (Rotterdam, Netherlands)
- Mieke R. Van Bockstal (Woluwe-Saint-Lambert, Belgium)
- Floris H. Groenendijk (Rotterdam, Netherlands)
- Thierry P. Van den Bosch (Rotterdam, Netherlands)
- Pieter Westenend (No City Provided, Namibia)
- Carolien H. Van Deurzen (Rotterdam, Netherlands)
Speakers
- Marie Colombe Agahozo (Rotterdam, Netherlands)
186P - HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome
Authors
- Elisa Agostinetto (Rozzano, Italy)
- Giovanna Masci (Rozzano, Italy)
- Laura Giordano (Rozzano, Italy)
- Agnese Losurdo (Rozzano, Italy)
- Rita De Sanctis (Rozzano, Italy)
- Rosalba Torrisi (Rozzano, Italy)
- Monica Zuradelli (Rozzano, Italy)
- Marta Scorsetti (Rozzano, Italy)
- Armando Santoro (Rozzano, Italy)
Speakers
- Elisa Agostinetto (Rozzano, Italy)
97P - Adjuvant trastuzumab in stage I breast cancer with the tumour size < 1 cm: Our centre experience
Authors
- Helena Belikova (Glasgow, United Kingdom)
- Abdulla Alhasso (Glasgow, United Kingdom)
Speakers
- Helena Belikova (Glasgow, United Kingdom)
126P - Clinical outcome of early stage breast cancer patients with 1 to 3 positive axillary lymph nodes: A single institution experience
Authors
- ASHA ARJUNAN (Thiruvananthapuram (Trivandrum), India)
- Shabna Abbas (Thiruvananthapuram (Trivandrum), India)
- Preethi S. George (Thiruvananthapuram (Trivandrum), India)
Speakers
- ASHA ARJUNAN (Thiruvananthapuram (Trivandrum), India)
205P - A prospective, multicentre, randomized trial comparing vascular access strategies for patients receiving non-trastuzumab containing chemotherapy for early stage breast cancer
Authors
- Arif A. Awan (Ottawa, Canada)
- Bassam Basulaiman (Ottawa, Canada)
- Andrew Robinson (Kingston, ON, Canada)
- Carol Stober (Ottawa, Canada)
- Dean Fergusson (Ottawa, Canada)
- Anil Abraham Joy (Edmonton, Alberta, Canada)
- Lisa Vandermeer (Ottawa, Canada)
- Ranjeeta Mallick (Ottawa, Canada)
- Deanna Saunders (Ottawa, Canada)
- Mark Clemons (Ottawa, Canada)
Speakers
- Arif A. Awan (Ottawa, Canada)
11P - Mammographic density change and risk of breast cancer
Authors
- Shadi Azam (Stockholm, Sweden)
- Mikael Eriksson (Stockholm, Sweden)
- Arvid Sjölander (Stockholm, Sweden)
- Roxanna Hellgren (Stockholm, Sweden)
- Marike Gabrielson (Stockholm, Sweden)
- Kamila Czene (Stockholm, Sweden)
- Per Hall (Stockholm, Sweden)
Speakers
- Shadi Azam (Stockholm, Sweden)
190P - Non-vigorous physical activity and the risk of breast cancer among Nigerian women
Authors
- Samuel O. Azubuike (Newcastle upon Tyne, United Kingdom)
- Louise Hayes (Newcastle upon Tyne, United Kingdom)
- Richard McNally (Newcastle upon Tyne, United Kingdom)
Speakers
- Samuel O. Azubuike (Newcastle upon Tyne, United Kingdom)
113P - The aromatase inactivator exemestane suppresses serum leptin levels significantly in vivo - in contrast to the aromatase inhibitor letrozole
Authors
- Nazli Bahrami (Lorenskog, Norway)
- Shakila Jabeen (Lorenskog, Norway)
- Torill Sauer (Lorenskog, Norway)
- Vessela N. Kristensen (Lorenskog, Norway)
- Joanna M. Gundersen (Lorenskog, Norway)
- Jürgen Geisler (Oslo, Norway)
Speakers
- Nazli Bahrami (Lorenskog, Norway)
120P - Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
Authors
- Bernardo L. Rapoport (Sandton, South Africa)
- Jacqui Barnard-Tidy (Johannesburg, Gauteng, South Africa)
- Ronwyn I. Van Eeden (Sandton, South Africa)
- Teresa Smit (Sandton, South Africa)
- Simon Nayler (Johannesburg, South Africa)
- Carol Benn (Johannesburg, South Africa)
Speakers
- Bernardo L. Rapoport (Sandton, South Africa)
83TiP - RESCUE: Reaching for evidence-based chemotherapy use in endocrine sensitive breast cancer - A prospective non-interventional study on risk assessment by the endopredict test and long-term patient outcome in early luminal breast cancer
Authors
- Johannes Ettl (Munich, Germany)
- Jens-Uwe Blohmer (Berlin, Germany)
- Carsten Denkert (Marburg, Germany)
- Lea Beier (Berlin, Germany)
- Evelyn Klein (München, Germany)
- Petra Neuser (Marburg, Germany)
- Maren Keller (Berlin, Germany)
- Michael Untch (Berlin, Germany)
- Michael Wittenberg (Marburg, Germany)
- Marion Kiechle (München, Germany)
Speakers
- Johannes Ettl (Munich, Germany)
175P - A four-year study of epidemiological trends of breast cancer in a Haitian cancer program
Authors
- Joseph Jr Bernard (Port-au-Prince, Haiti)
- Lynn Gabrielle Alexis (Port-au-Prince, Haiti)
- Vincent Jr Degennaro (Port-au-Prince, Haiti)
Speakers
- Joseph Jr Bernard (Port-au-Prince, Haiti)
177P - Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience
Authors
- Ewelina M. Biskup (Basel, Switzerland)
- Céline Montavon Sartorius (Basel, Switzerland)
- Andreas Müller (Winterthur, Switzerland)
- Cornelia Leo (Baden, Switzerland)
- Catrina Uhlmann Nussbaum (Olten, Switzerland)
- Daniel Koychev (Rapperswil, Switzerland)
- Alexander Schreiber (Aarau, Switzerland)
- Christian Taverna (Muensterlingen, Switzerland)
- David Thorn (Basel, Switzerland)
- Marcus Vetter (Basel, Switzerland)
Speakers
- Ewelina M. Biskup (Basel, Switzerland)